HOME >> BIOLOGY >> NEWS
ACS Weekly PressPac -- September 6, 2006

ies of 11 percent, whereas most new solar cells have efficiencies between 4 percent and 5 percent, according to Michael Graetzel, Ph.D., a chemist at the Swiss Federal Institute of Technology, Lausanne.

Graetzel's cells, which can be engineered into inexpensive, flexible sheets, could be used as coatings on glass windows to supply electric power to homes and businesses or as coatings on tents to supply power for soldiers in the field. The cells could be used in consumer applications within two to three years, the researcher says.

CONTACT: Michael Graetzel, Ph.D.
Swiss Federal Institute of Technology
Switzerland
Phone: 41-21-693-3112
Fax: 41-21-693-4111
e-mail: Michael.graetzel@epfl.ch


ARTICLE #3 EMBARGOED FOR: Sunday, Sept. 10, 5:30 p.m., EDT
'Conversation stoppers' fight deadly bacterial infections

NOTE: A press conference on this topic with call-in audio participation will be held at 10 a.m. Sept. 11. Reporters are asked to call five to ten minutes prior to the scheduled start time. Reporters will be asked to identify themselves, their affiliations and the topic of the briefing. Call 800-967-7140 (domestic); 719-457-2629 (international).

Bacterial infections are becoming more deadly worldwide due to increased resistance to antibiotics. Now Helen E. Blackwell and colleagues have developed a powerful strategy to fight these deadly infections: Instead of killing the bacteria directly, the scientists designed a group of compounds that can block the chemical signals that the bacteria use to communicate in an effort to stop their spread.

These compounds, small organic molecules that they call 'conversation stoppers,' could help deliver a powerful one-two punch to knock out deadly infections when combined with the killing power of antibiotics. In addition, these 'conversation stoppers' do not target bac
'"/>

Contact: Michael Woods
m_woods@acs.org
American Chemical Society
12-Sep-2006


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. American Chemical Societys Weekly PressPac -- Aug. 1, 2007
3. American Chemical Societys Weekly PressPac -- July 25, 2007
4. American Chemical Societys Weekly PressPac -- July 18, 2007
5. American Chemical Societys Weekly PressPac -- July 11, 2007
6. American Chemical Societys Weekly PressPac -- June 27/July 3, 2007
7. American Chemical Societys Weekly PressPac -- June 20, 2007
8. American Chemical Societys Weekly PressPac -- June 13, 2007
9. American Chemical Societys Weekly PressPac -- May 30, 2007
10. ACS News Service Weekly PressPac -- May 23, 2007
11. ACS News Service Weekly PressPac -- May 16, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ACS Weekly PressPac September

(Date:6/16/2015)... , June 16, 2015 /CNW Telbec/ - handyem ... centralized around the incorporation of handyem,s HPC-150 portable ... laboratory, the Mo-POD™. This unprecedented model of mobile ... Conference at the Pennsylvania ... June 15 th to 18 th ...
(Date:6/16/2015)... , June 16, 2015 Fingerprint Cards ... fingerprint sensors in the company,s portfolio from one of its ... planned to mainly take place during the third quarter 2015. ... Asia . Jörgen Lantto, CEO of ...   the   growing interest from smartphone OEMs in integrating ...
(Date:6/15/2015)... June 16, 2015 According to ... by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, ... 2020" published by MarketsandMarkets, The Natural Language Processing Market ... CAGR of 18.4% for the forecast period 2015-2020. ... 46 F igures spread   through 155 P ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2Natural Language Processing Market Worth $13.4 Billion by 2020 2Natural Language Processing Market Worth $13.4 Billion by 2020 3Natural Language Processing Market Worth $13.4 Billion by 2020 4Natural Language Processing Market Worth $13.4 Billion by 2020 5
(Date:7/2/2015)... ... July 02, 2015 , ... In’Tech ... surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, Inc ... provider of surgical instruments to the Spine Industry. The acquisition of Turner Medical ...
(Date:7/1/2015)... , July 1, 2015   Decision ... frequently cited advantages of Otezla are its oral ... profile, as reported by surveyed rheumatologists. Otezla was ... for the treatment of active psoriatic arthritis in ... current standard of care includes conventional oral treatments ...
(Date:7/1/2015)... ALTO, Calif. , July 1, 2015 /PRNewswire/ ... focused on the development of groundbreaking drugs to ... (ALS), announced today that Robert G. Miller ... Center at Sutter Health,s California Pacific Medical Center ... The ALS Association for $1.5 million to help ...
(Date:7/1/2015)... ... July 01, 2015 , ... A newly launched business plan ... lower the barriers to innovation in life sciences R&D. The Pistoia Alliance President’s Startup ... prizes of US$15,000 and a period of expert mentorship from a senior industry figure ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Pistoia Alliance Launches Startup Challenge 2Pistoia Alliance Launches Startup Challenge 3
Cached News: